Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer (Q71065911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

H Ito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Y Yonemura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

H Fujita

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

K Tsuchihara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

T Kawamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

N Nojima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

T Fujimura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

H Nose

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Y Endo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

T Sasaki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

427

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

487-496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00199509

15 October 2019

exact match

0 references

cites work

Antibodies to plasminogen activator inhibit human tumor metastasis

1 reference

12 December 2020

Growth factors in the regulation of pericellular proteolysis: a review

1 reference

12 December 2020

Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA)

1 reference

12 December 2020

The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumors

1 reference

12 December 2020

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

1 reference

12 December 2020

Plasminogen activator profiles in neoplastic tissues of the human colon

1 reference

12 December 2020

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor

1 reference

12 December 2020

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

12 December 2020

Plasminogen activator inhibitors--a review

1 reference

12 December 2020

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer

1 reference

12 December 2020

Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines

1 reference

12 December 2020

Prognostic value of urokinase-type plasminogen activators in gastric-cancer

1 reference

12 December 2020

Plasminogen activator inhibitor (PAI-1) in plasma and platelets

1 reference

12 December 2020

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

1 reference

12 December 2020

Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane

1 reference

12 December 2020

Immunohistochemical analysis of plasminogen activator expression in human colorectal carcinomas: correlation with CEA distribution and tumor cell kinetics

1 reference

12 December 2020

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

1 reference

12 December 2020

Cell-associated plasminogen activation: regulation and physiological functions

1 reference

12 December 2020

Type 1 plasminogen activator inhibitor

1 reference

12 December 2020

Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

1 reference

12 December 2020

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma

1 reference

12 December 2020

Partial Purification and Properties of Urokinase Inhibitor from Human Placenta

1 reference

12 December 2020

Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma

1 reference

12 December 2020

Content and characterization of plasminogen activators in human lung tumors and normal lung tissue

1 reference

12 December 2020

Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines

1 reference

12 December 2020

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

1 reference

12 December 2020

Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas

1 reference

12 December 2020

Immunochemical localization of heparanase in mouse and human melanomas

1 reference

12 December 2020

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

12 December 2020

Plasminogen activator inhibitor 1 in human carcinoma tissues

1 reference

12 December 2020

Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

1 reference

12 December 2020

Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.

1 reference

12 December 2020

The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification

1 reference

12 December 2020

Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states

1 reference

12 December 2020

Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis

1 reference

12 December 2020

Relationship between plasminogen activators and stomach carcinoma stage

1 reference

12 December 2020

Plasminogen activator inhibitors

1 reference

12 December 2020

Role of collagenases in tumor cell invasion

1 reference

12 December 2020

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

12 December 2020

Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis

1 reference

12 December 2020

Plasminogen activators in human gastric cancers: correlation with DNA ploidy and immunohistochemical staining

1 reference

12 December 2020

Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma

1 reference

12 December 2020

Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates

1 reference

12 December 2020

Growth Factors in the Regulation of Plasminogen-Plasmin System in Tumor Cells

1 reference

12 December 2020

Defining the invasive phenotype of proximal gastric cancer cells

1 reference

12 December 2020

Antigen expression associated with lymph node metastasis in gastric adenocarcinomas

1 reference

12 December 2020

Plasminogen activators in (pre)malignant conditions of the colorectum

1 reference

12 December 2020

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1 reference

12 December 2020

Proteolytic degradation of extracellular matrix in tumor invasion

1 reference

12 December 2020

Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells

1 reference

12 December 2020

Differentiation of growth patterns of early gastric carcinoma determined by cytophotometric0 DNA analysis

1 reference

12 December 2020

Immunological characterization of plasminogen activator activities in human tissues and body fluids

1 reference

12 December 2020

Plasminogen activator system in human breast cancer

1 reference

12 December 2020

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas

1 reference

12 December 2020

Localization of plasminogen activators in human colon cancer by immunoperoxidase staining

1 reference

12 December 2020

Prognostic significance of dna index, multiploidy, and S-phase fraction in ovarian cancer

1 reference

12 December 2020

The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining

1 reference

12 December 2020

The Biology of Cancer Invasion and Metastasis

1 reference

12 December 2020

Fibrinolytic pathways and the endothelium

1 reference

12 December 2020

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

12 December 2020

Type-1 plasminogen activator inhibitor in human breast carcinomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8624578%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference